Financial Ratios

MJ PHARMACEUTICALS LTD.

NSE : NABSE : 507751ISIN CODE : Industry : Finance - InvestmentHouse : Private
BSE5.250 (0 %)
PREV CLOSE ( ) 5.25
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2014Mar2013Mar2012Mar2011Mar2010
Operational & Financial Ratios
   Earnings Per Share (Rs)2806.651713.264621.234558.292494.49
   CEPS(Rs)2806.651713.264621.234558.292494.49
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)24191.7421385.0919671.8314992.9710434.68
   Tax Rate(%)2.573.240.8310.330.26
Margin Ratios
   Core EBITDA Margin(%)99.8488.3899.4589.0999.87
   EBIT Margin(%)120.3388.6099.9492.3799.87
   Pre Tax Margin(%)117.3987.4599.9492.3799.87
   PAT Margin (%)114.3884.6199.1182.8299.61
   Cash Profit Margin (%)114.3884.6199.1182.8299.61
Performance Ratios
   ROA(%)9.065.5316.9723.7518.21
   ROE(%)12.328.3526.6635.8523.91
   ROCE(%)9.565.8017.1126.5118.29
   Asset Turnover(x)0.080.070.170.290.18
   Sales/Fixed Asset(x)
   Working Capital/Sales(x)2.7054.4458.47153.431.59
Efficiency Ratios
   Fixed Capital/Sales(x)0.000.000.000.000.00
   Receivable days0.000.000.000.000.00
   Inventory Days0.000.000.000.000.00
   Payable days
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)2.225.272.161.761.29
   EV/Core EBITDA(x)1.855.952.161.911.30
   EV/EBIT(x)1.855.952.161.911.30
   EV/CE(x)0.180.330.340.390.24
   M Cap / Sales0.000.000.000.000.00
Growth Ratio
   Net Sales Growth(%)21.19-56.58-15.28119.780.00
   Core EBITDA Growth(%)64.59-61.50-8.33103.260.00
   EBIT Growth(%)64.59-61.50-8.33103.260.00
   PAT Growth(%)63.82-62.931.3882.730.00
   EPS Growth(%)63.82-62.931.3882.730.00
Financial Stability Ratios
   Total Debt/Equity(x)0.230.500.510.650.31
   Current Ratio(x)342.1914.616.5522.7059.58
   Quick Ratio(x)342.1914.616.5522.7059.58
   Interest Cover(x)40.9677.140.000.000.00
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.